Urgent.News

What's breaking now, across thousands of outlets.

World

High cost of GLP-1s drives some to seek cheaper, unregulated versions

Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths to get their hands on unregulated versions. Stephanie Sy reports for our series, GLP-1s: Reshaping America.

We haven't written up this one. PBS NewsHour has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at pbs.org →

More in World

More from Tuesday 6 October →